Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Asymmetric Diabetic Proximal Motor Neuropathy

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Research Excerpts

ExcerptRelevanceReference
"The streptozotocin-induced diabetic rat model was used to compare the efficacy of duloxetine, 5-HT, the 5-HT(2A) receptor agonist [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI)] and two antagonists (ketanserin and pruvanserin) on tactile allodynia."3.77A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy. ( Jolivalt, CG; Mixcoatl-Zecuatl, T, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mixcoatl-Zecuatl, T1
Jolivalt, CG1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
    British journal of pharmacology, 2011, Volume: 164, Issue:1

    Topics: Amphetamines; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Duloxetine Hydrochlor

2011